Director, Epidemiology
Target RWE
Durham, United States
Kathleen E. Hurwitz, ScD, Director of Epidemiology at Target RWE, is an established epidemiologist with extensive experience in the design, conduct, and analysis of clinical research using both randomized trial and observational designs. She holds a doctoral degree from the Harvard T.H. Chan School of Public Health, where she also completed her post-doctoral training and served five years as a Research Scientist in the Department of Biostatistics prior to joining Target RWE in 2022. Previously, Kathleen oversaw all statistical and quantitative efforts for a large (7 years duration, ~$80 million total cost) pragmatic trial involving more than 100,000 individuals residing in 30 communities. Furthermore, she was the Lead Epidemiologist for a multi-site randomized trial of neonatal male circumcision and a prospective cohort study of treatment outcomes among infants hospitalized for severe pneumonia in Botswana. Kathleen has also led statistical activities for multiple real-world studies of uptake and adherence to pre-exposure prophylaxis (PrEP) for HIV prevention domestically and in Uganda and South Africa. In addition to her extensive applied experience, Kathleen has been deeply involved in the development and application of novel epidemiologic and statistical methods for causal inference including most recently negative control outcomes for assessing residual bias and clone-censor-weight designs for comparative effectiveness and safety research. She has authored over 65 publications that have appeared in leading medical journals, including the New England Journal of Medicine, Lancet HIV, The Journal of Infectious Diseases, American Journal of Epidemiology, and Statistics in Medicine. Kathleen previously published under her maiden name, Wirth.
Disclosure information not submitted.
Methods and New Approaches in Pragmatic Trials
Wednesday, August 23, 2023
2:00 PM – 6:00 PM ADT